@jrouldz Absolutely. I have a friend with treatment-resistant depression, so I’m hopefully this type of thing will become an accessible option. Alzheimer’s would just be a huge bonus and from a financial perspective an enormous TAM.
@jrouldz I’m torn on this. I love the idea of having more time to focus on longer term growth without near-sighted shareholders getting spooked about a 3-month period, but I also think this is going to lead to much bigger earnings reactions if companies choose to only report twice a year.
@ZaStocks I’ve been patiently waiting for that narrative shift. Sell-offs of companies like ADBE that are still bringing in tons of cash really felt overblown.